Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer

Go back to Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer
(NASDAQ: IOVA) Delayed: 8.29 -0.7 (7.79%)
Previous Close $8.99    52 Week High
Open $9.08    52 Week Low
Day High $9.30    P/E N/A 
Day Low $8.15    EPS
Volume 27,805,734